TrialAmerican journal of clinical dermatology2019

A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.

Dee Anna Glaser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.